Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study
暂无分享,去创建一个
A. Young | W. Drevets | H. Manji | G. Sanacora | P. Lim | E. Wajs | R. Morrison | J. Singh | A. Sulaiman | J. Paik | R. Lane | D. Hough | E. Daly | S. Kasper | R. Holder | A. Leah | C. -. Li